Adage Capital Partners’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $962M | Buy |
|
|||||
|
2021
Q1 | $649M | Buy |
|
|||||
|
2020
Q4 | $456M | Buy |
|
|||||
|
2020
Q3 | $92.7M | Sell |
|
|||||
|
2020
Q2 | $109M | Sell |
|
|||||
|
2020
Q1 | $94.7M | Buy |
|
|||||
|
2019
Q4 | $87.5M | Buy |
|
|||||
|
2019
Q3 | $55.5M | Sell |
|
|||||
|
2019
Q2 | $81.1M | Buy |
|
|||||
|
2019
Q1 | $66M | Buy |
|
|||||
|
2018
Q4 | $13.5M | Sell |
|
|||||
|
2018
Q3 | $27M | Buy |
|
|||||
|
2018
Q2 | $2.54M | Buy |
|
|||||
|
2018
Q1 | $1.1M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $54.1M | Buy |
|
|||||
|
2017
Q2 | $42.6M | Buy |
|
|||||
|
2017
Q1 | $28.1M | Sell |
|
|||||
|
2016
Q4 | $32.4M | Buy |
|
|||||
|
2016
Q3 | $19.7M | Buy |
|
|||||
|
2016
Q2 | $3.66M | Sell |
|
|||||
|
2016
Q1 | $9.54M | Sell |
|
|||||
|
2015
Q4 | $58.3M | Buy |
|
|||||
|
2015
Q3 | $43.8M | Sell |
|
|||||
|
2015
Q2 | $53.2M | Sell |
|
|||||
|
2015
Q1 | $53.9M | Sell |
|
|||||
|
2014
Q4 | $72.9M | Buy |
|
|||||
|
2014
Q3 | $53M | Sell |
|
|||||
|
2014
Q2 | $56.9M | Buy |
|
|||||
|
2014
Q1 | $53M | Sell |
|
|||||
|
2013
Q4 | $67.6M | Sell |
|
|||||
|
2013
Q3 | $68.8M | Sell |
|
|||||
|
2013
Q2 | $73.1M | Buy |
|